Braemar Closes $437.5M Three-Hotel Sale and Agrees to Sell Pier House Resort for $190M
BHR is trading near its 52-week low of $1.88 (9.0% above the low).
Summary
Braemar Hotels closed the $437.5M sale of three luxury hotels and agreed to sell the Pier House Resort for $190M, continuing a major asset disposition program amid an activist proxy battle.
Key Events · M&A and Partnerships · BHR
-
Three-Hotel Sale Completed
Closed the $437.5M sale of The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel, netting ~$432.7M in cash after transfer taxes and expenses.
-
Debt Repayment
Used $232.8M of proceeds to repay the mortgage loan partially secured by the three sold properties, reducing leverage.
-
New Pier House Sale Agreement
Entered an agreement on July 13, 2026 to sell the Pier House Resort & Spa in Key West for $190M in cash, subject to customary closing conditions.
-
Pro Forma Financial Impact
Pro forma statements show the three-hotel sale would have turned a $72.7M net loss in 2025 into $96.7M net income, and Q1 2026 EPS from $0.07 to $0.02, reflecting reduced scale.
Analysis · BHR · Real Estate & Construction
Braemar completed the $437.5 million sale of three luxury hotels — The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel — netting approximately $432.7 million in cash after taxes and expenses. The company used part of the proceeds to repay $232.8 million in mortgage debt, strengthening its balance sheet. Simultaneously, Braemar entered a new agreement to sell the Pier House Resort & Spa in Key West for $190 million, signaling continued asset monetization. These transactions come amid an ongoing proxy fight with activist investor Al Shams Investments, which has been pushing for strategic changes. The sales dramatically reshape Braemar's portfolio and provide significant liquidity, but also reduce the company's asset base and future earnings potential.
At the time of this filing, BHR was trading at $2.05 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $140.8M. The 52-week trading range was $1.88 to $3.19. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.